DoD Scleroderma Research Program

DoD Scleroderma Research Program
Idea Development Award
Amount of funding: Direct costs budgeted will not exceed $300,000 for applications with a single PI or $450,000 if applying under the New Investigator Collaboration Option. 
Purpose:  The IDA promotes ideas that are still in the early stages of development and have the potential to yield high-impact findings and new avenues of investigation. This award mechanism supports conceptually innovative high-risk/high-reward research that could lead to critical discoveries or major advancements in scleroderma research and/or improvements in patient care. Research projects should include a well-formulated, testable hypothesis based on strong preliminary data and scientific rationale.
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI.
For application submissions under the New Investigator Collaboration Option:
The FY21 SRP IDA mechanism encourages applications in which a New Investigator in the early stages of their career partners with an established scleroderma researcher (as demonstrated by current funding and recent publications). By the application submission deadline date, the New Investigator must:
- Have the freedom to pursue independent research goals without formal mentorship. Stanford clarification: the New Investigator must be an Independent investigator - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI. 
- Be an independent, early-career investigator within 10 years of completion of their terminal degree by the time of the application submission deadline (excluding time spent in residency or on family medical leave). 
- New Investigators working within a laboratory team are eligible to be named as the PI for the IDA - New Investigator Collaboration Option provided they can demonstrate they have the freedom to pursue independent research goals without formal mentorship. Graduate students and junior postdoctoral fellows with less than 3 years postdoctoral training by the application submission deadline are not eligible for this award.
- Must not have received National Institutes of Health (NIH) R01 funding.
- Must not have received a New Investigator Award previously from any program within the CDMRP.
Timeline:
Pre-application/Letter of intent (required) deadline: August 11, 2021 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) deadline: August 18, 2021
Full proposal deadline: August 25, 2021 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/srp

DoD Scleroderma Research Program
Translational Research Partnership Award
Amount of funding: Direct costs budgeted will not exceed $750,000
Purpose:  The FY21 SRP TRPA mechanism supports partnerships between clinicians, research scientists and other disciplines that will accelerate the movement of promising ideas in scleroderma into clinical applications. The ultimate goal of translational research is to move a concept or observation forward into clinical application that is relevant to active-duty Service Members, Veterans, other military beneficiaries, and the American public. This award supports the development of translational research collaborations between two or more investigators to address a central problem or question in scleroderma in a manner that would be less readily achievable through separate efforts.
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI. One partner in the collaboration must be a research scientist and another must be a clinician. If the PI is a clinician, they must be an M.D., M.D./Ph.D., or equivalent with clinical duties and/or responsibilities. At least one member of the partnership must have experience in either scleroderma research or scleroderma patient care as demonstrated by active funding and/or recent publications.
Timeline:
Pre-application/Letter of intent (required) deadline: August 11, 2021 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) deadline: August 18, 2021
Full proposal deadline: August 25, 2021 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/srp

Please include your institutional official's name (RPM/RMG or CGO/OSR) as business official in the pre-application/LOI.

eBRAP Funding Opportunities and Forms (including the General Application Instructions).